A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
Public ClinicalTrials.gov record NCT01609140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Placebo-Controlled, Double-Blind Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and cholesterol lowering effects of MPSK3169A when given as subcutaneous (SC) injections over a 24-week period to patients with a high risk of cardiovascular events and LDL-c levels well above goal.
Study identification
- NCT ID
- NCT01609140
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 248 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2012
- Primary completion
- Apr 30, 2013
- Completion
- Jun 30, 2013
- Last update posted
- Nov 1, 2016
2012 – 2013
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Goodyear | Arizona | 85395 | — |
| Not listed | Carmichael | California | 95608 | — |
| Not listed | Spring Valley | California | 91978 | — |
| Not listed | Walnut Creek | California | 94598 | — |
| Not listed | Wildomar | California | 92595 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Ponte Verde | Florida | 32081 | — |
| Not listed | Boise | Idaho | 83704 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Auburn | Maine | 04210 | — |
| Not listed | Baltimore | Maryland | 21209 | — |
| Not listed | Bethesda | Maryland | 20817 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Rochester | New York | 14609 | — |
| Not listed | Wilmington | North Carolina | 28401 | — |
| Not listed | Fargo | North Dakota | 58103 | — |
| Not listed | Cincinnati | Ohio | 45212 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Springdale | Ohio | 45246 | — |
| Not listed | Oklahoma City | Oklahoma | 73103 | — |
| Not listed | Tulsa | Oklahoma | 74136 | — |
| Not listed | Greer | South Carolina | 29650 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Spartanburg | South Carolina | 29303 | — |
| Not listed | Rapid City | South Dakota | 57701 | — |
| Not listed | Bristol | Tennessee | 37620 | — |
| Not listed | Knoxville | Tennessee | 27912 | — |
| Not listed | Boerne | Texas | 78006 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01609140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2016 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01609140 live on ClinicalTrials.gov.